Envoy Medical (COCHW) Convertible Debt (2022 - 2023)
Envoy Medical recorded quarterly Convertible Debt of $2.5 million in Q4 2023, down 37.5% quarter-over-quarter from $4.0 million in Q3 2023, and down 92.51% year-over-year from $33.4 million in Q4 2022.
Envoy Medical's Convertible Debt history runs 2 years deep, the most recent figure standing at $2.5 million for Q4 2023.
- In Q4 2023, Convertible Debt fell 92.51% year-over-year to $2.5 million; the TTM figure through Dec 2023 stood at $2.5 million (down 92.51% YoY), while the FY2023 annual figure was $2.5 million, down 92.51% from the prior year.
- Convertible Debt came in at $2.5 million for Q4 2023 at Envoy Medical, down from $4.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $33.4 million in Q4 2022 to a low of $2.5 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Envoy Medical | - | - | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 14.70 Mn |
| Dec 31, 2022 | 33.40 Mn |